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CASE REPORT
A 2-month-old female, Caucasian infant was 
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huge amount of milk was drained from the oral cavity 
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Figure 1. A - Anterior vision of the visceral block showing multiple hepatic metastases; B - Gross features of the 
paravertebral tumoral mass.
Figure 2. Photomicrography of: A - Neuroblastoma with areas of calcification and lymphatic neoplastic embolization 
(HE,  200x); B  -  Hepatic  infiltration  by  neuroblastoma  (HE,  100x); C -  In  situ  adrenal  neuroblastoma  (HE,  50x); 
D - Nesidioblastosis (immunohistochemistry for insulin, 400x).
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in situ neuroblastoma was also found in the adrenal 
gland (Figure 2C). Nesidioblastosis was evidenced in 
the pancreas (Figure 2D).
Histological  f indings  associated with  the 













most common extra-cranial solid tumor of infancy.5




Other common sites include the neck, thorax, and 
pelvis.6 Unusual primary sites have been described, 
and involve the thymus, lungs, kidney, mediastinum, 
stomach, and cauda equina.7











diagnosis with the other small-blue-round-cell tumors.
In 1984, Shimada et al.8 proposed the most useful 








cell nodules, nodules into the tumor mass, the 
differentiation grade of the tumoral cells, and the 
proportion of cells exhibiting mitosis and karyorrhexis 
(Table 1).
Table 1. Favorable vs. unfavorable histology in neuroblastic tumors


















Nodular * * Unfavorable or favorable*
Intermixed NA Any Favorable
GN Mature or maturing NA Any Favorable
* = the determination of favorable or unfavorable histology in nodular GNB is based on the nodular NB component; GN = ganglioneuroma; 
GNB = ganglioneuroblastoma; MKI: mitosis/karyorrhexis index; NA = not applicable; NB = neuroblastoma.
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disease does not interfere with the staging, although 
the information of surgical margins should be included 
in  the anatopathological  report. Stage 3 tumors, 
considered high-stage disease, are unresectable and 
extend beyond the middle line. Stage 4 includes all 
patients over 12 months of age who present metastatic 
disease  (lymph nodes, bone marrow,  liver,  and 
other sites). Neuroblastoma stage 4S represents the 















common site for distant metastasis followed by the 
placenta, retroperitoneal  lymph nodes, bone, skin, 
and umbilical cord. The lungs and the brain are rarely 
involved.14
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examination, there is an increasing number of diagnoses 
of congenital neuroblastoma.  It  is noteworthy to 





observed that all cases showed a favorable histology 
and a good prognosis during follow-up. Surgical 




















L1/L2 GN maturing GNB intermixed A: very low
L1 Any except NA B: very Low
GN maturing or
GNB intermixed Amp K: high
L2 Any except No D: low
< 18 GN maturing or
GNB intermixed
NA Yes G: intermediate
No E: low








M < 18 NA Hyperdiploid F: low
< 12 NA Diploid I: intermediate
12-18 NA Diploid J: intermediate
< 18 Amp O:high
≥ 18 P: high
MS NA No C: very low
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stage 4 congenital neuroblastoma. The presence of 











coincidence, but we dare to remind readers that this 
coexistence may be related to the same histogenesis of 
both cells. Some cells derived from the neural crest may 
differentiate in peculiar neuroendocrine structures, 
which are generally named as chromaffin bodies. 
Nesidioblastosis develops from these cells, which will 
give origin to Langerhans islets.22 The association 
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